Entity/Public Space Stock Epinephrine

Stock epinephrine is rapidly moving beyond the school walls and out to public venues – from theme parks, restaurants and sports arenas to daycare centers and more.

Thirty-six states have now passed what are called “entity laws” (as of July 1, 2019), legislation that permits venues to maintain an epinephrine auto-injector, with the intention of reducing the time it takes to get lifesaving epinephrine to a person having a sudden anaphylactic reaction.

States colored red are without entity legislation.

Click on the state listings below to read the legislation.

 

 Green states:  Red states:
Alaska Delaware
Alabama Hawaii
Arkansas Kansas
Arizona Louisiana
California Maryland
Colorado Massachusetts
Connecticut  Mississippi
District of Columbia   Montana
Florida Nebraska
Georgia New Mexico
Idaho North Dakota
Illinois South Dakota
Indiana Vermont
Iowa Virginia
Kentucky Wyoming
Michigan
Minnesota
Missouri
Maine
Nevada
New Hampshire
New Jersey
New York
North Carolina
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
Tennessee
Texas
Utah
Washington
West Virginia
Wisconsin

For questions and to get involved in Entity Legislation in your state, contact Charmayne Anderson at canderson@allergyasthmanetwork.org or 800.878.4403.